GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (WBO:AZNA) » Definitions » Cyclically Adjusted Book per Share

AstraZeneca (WBO:AZNA) Cyclically Adjusted Book per Share : €7.65 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AstraZeneca Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

AstraZeneca's adjusted book value per share for the three months ended in Mar. 2024 was €11.111. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €7.65 for the trailing ten years ended in Mar. 2024.

During the past 12 months, AstraZeneca's average Cyclically Adjusted Book Growth Rate was 7.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 8.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of AstraZeneca was 12.50% per year. The lowest was -0.90% per year. And the median was 5.70% per year.

As of today (2024-06-04), AstraZeneca's current stock price is €73.00. AstraZeneca's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €7.65. AstraZeneca's Cyclically Adjusted PB Ratio of today is 9.54.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AstraZeneca was 10.10. The lowest was 3.78. And the median was 5.62.


AstraZeneca Cyclically Adjusted Book per Share Historical Data

The historical data trend for AstraZeneca's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Cyclically Adjusted Book per Share Chart

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 7.26

AstraZeneca Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 7.26 7.65

Competitive Comparison of AstraZeneca's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, AstraZeneca's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Cyclically Adjusted PB Ratio falls into.



AstraZeneca Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AstraZeneca's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.111/131.6000*131.6000
=11.111

Current CPI (Mar. 2024) = 131.6000.

AstraZeneca Quarterly Data

Book Value per Share CPI Adj_Book
201406 6.419 99.800 8.464
201409 6.281 100.000 8.266
201412 6.301 99.900 8.300
201503 6.190 99.600 8.179
201506 6.444 100.100 8.472
201509 6.115 100.200 8.031
201512 6.714 100.400 8.800
201603 5.232 100.400 6.858
201606 4.760 101.000 6.202
201609 4.604 101.500 5.969
201612 5.565 102.200 7.166
201703 4.796 102.700 6.146
201706 4.800 103.500 6.103
201709 4.548 104.300 5.738
201712 4.992 105.000 6.257
201803 4.135 105.100 5.178
201806 4.273 105.900 5.310
201809 4.037 106.600 4.984
201812 4.325 107.100 5.314
201903 3.536 107.000 4.349
201906 4.570 107.900 5.574
201909 4.210 108.400 5.111
201912 4.502 108.500 5.460
202003 3.717 108.600 4.504
202006 4.140 108.800 5.008
202009 3.945 109.200 4.754
202012 4.891 109.400 5.884
202103 4.617 109.700 5.539
202106 4.956 111.400 5.855
202109 10.904 112.400 12.767
202112 11.215 114.700 12.867
202203 10.648 116.500 12.028
202206 10.969 120.500 11.979
202209 11.451 122.300 12.322
202212 11.280 125.300 11.847
202303 10.784 126.800 11.192
202306 11.134 129.400 11.323
202309 11.244 130.100 11.374
202312 11.578 130.500 11.676
202403 11.111 131.600 11.111

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


AstraZeneca  (WBO:AZNA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AstraZeneca's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=73.00/7.65
=9.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AstraZeneca was 10.10. The lowest was 3.78. And the median was 5.62.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


AstraZeneca Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca (WBO:AZNA) Business Description

Industry
Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

AstraZeneca (WBO:AZNA) Headlines

No Headlines